Epidemiology of major age-related diseases in women compared to men

Aging Clinical and Experimental Research

Volumn 12, Issue 2, 2000, Pages 93-105

  Giampaoli, S ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Elderly; Epidemiology; Gender difference; Morbidity; Mortality

Indexed keywords

ARTICLE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENDER; INDUSTRIALIZATION; LIFE EXPECTANCY; LONGEVITY; MORBIDITY; MORTALITY; QUALITY OF LIFE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0034046725     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03339896     Document Type: Article

References (124)

1. EU population in 2050, Girls could live to 87 & boys to 83. Total population back to 1950 level? EUROSTAT Statistics in focus, population and social conditions, No. 7/97. Beyond the predictable: the demographic changes in the E.U. up to 2050, No. 4597, 24 June 1997.
2. National Center for Health Statistics, United States, 1996-97, and Injury Chartbook. National Center for Health Statistics, Hyattsville, Md, 1997.
3. Fried L., Bush T.: Morbidity as a focus of preventive health care in the elderly. Epidemiol. Rev. 10: 48-64, 1988.
4. Trussel J.: Women's longevity. Science 270: 720-721, 1995.
5. Carter L.R., Lee R.D.: Modelling and forecasting US sex differential in mortality. Int. J. Forecasting 8: 393-412, 1991.
6. Bell F.C., Wade A.H., Goss S.C.: Life tables for the United States Social Security Area 1900-2080. Actuarial Study No. 107, US Department of Health and Human Services, Social Security Administration Office and Actuary, Washington DC, 1992.
7. Jecker N.S.: Age-based rationing and women. JAMA 266: 3012-3015, 1991.
8. Wenger N., Speroff L., Packard B.: Cardiovascular health and disease in women. N. Engl. J. Med. 329: 247-256, 1993.
9. McMillen M.M.: Differential mortality by sex in fetal and neonatal death. Science 204: 89-91, 1979.
10. Holder C.: Why do women live longer than men? Science 238: 158-160, 1987.
11. World Health Organisation Regional Office for Europe: Health for all data base. Copenhagen, June 1999.
12. Lerner D.J., Kannel W.B.: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 111: 383-390, 1986.
13. Coronary heart disease incidence by sex: United States, 1971-1987. MMWR 41: 526-529, 1992.
14. Wingard D.L., Cohn B.A., Kaplan G.A., Cirillo P.M., Cohen R.D.: Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am. J. Epidemiol. 130: 601-610, 1989.
15. Pisa Z., Uemura K.: Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1967-1977. World Health Stat. Q. 35: 11-47, 1982.
16. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E.: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 353: 1547-1557, 1999.
17. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A., for the WHO MONICA Project: Myocardial infarction and coronary deaths in the World Health Organisation MONICA Project. Registration procedure, event rates and case-fatality in 38 populations from 21 countries in 4 continents. Circulation 90: 583-612, 1994.
18. Rosamond W., Chambless L., Folsom A., Cooper L., Conwill D., Clegg L., Wang C., Heiss G.: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 339: 861-867, 1998.
19. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P.: Survival trends, coronary event rates and the MONICA Project. Lancet 354: 863-864, 1999.
20. Chambless L., Keil U., Dobson A., Mahaonen M., Kuulasmaa K., Rajakangas A., Lowel H., Tunstall-Pedoe H.: Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985 to 1990. Circulation 96: 3849-3859, 1997.
21. Lowel H., Dobson A., Keil U., Herman B., Hobbs M., Stewart A., Arstila M., Miettinen H., Mustaniemi H., Tuomilehto J.: Coronary heart disease case fatality in four countries. Circulation 88: 2524-2531, 1993.
22. Rosamond W., Broda G., Kawalec E., Rywik S., Pajak A., Cooper L., Chambless L.: Comparison of medical care and survival of hospitalised patients with acute myocardial infarction in Poland and the United States. Am. J. Cardiol. 83: 1180-1185, 1999.
23. Hennekens C.: Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3 and GUSTO-1. Clin. Cardiol. 17 (Suppl. 1): 115-117, 1994.
24. Teo K., Yusuf S., Furberg C.: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 270: 1589-1595, 1993.
25. ISIS-2 Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349-360, 1988.
26. Kostis J.B., Wilson A.C., O'Dowd K., Gregory P., Chelton S., Cosgrove N.M., Chirala A., Cui T., for the MIDAS Study Group: Sex differences in the management and long-term outcome of acute myocardial infarction: a state-wide study. Circulation 90: 1715-1730, 1994.
27. Vaccarino V., Krumholz H.M., Berkman L.F., Horwitz R.I.: Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 91: 1861-1871, 1995.
28. Fiebach N., Viscoli C., Horvitz R.: Difference between women and men in survival after myocardial infarction. Biology or methodology? JAMA 263: 1092-1096, 1990.
29. Goldberg R.J., Gorak E.J., Yarzebski J., Hosmer D.W., Dalen P., Gore J.M., Alpert J.S., Dalen J.E.: A community wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary artery disease. Circulation 87: 1947-1953, 1993.
30. Robinson K., Conroy R.M., Mulcahy R., Hickey N.: The 15-year prognosis of a first acute coronary episode in women. Eur. Heart J. 13: 67-69, 1992.
31. Greenland P., Reicher-Reiss H., Goldbourt U., Behar S.: In-hospital and 1 year mortality in 1524 women after myocardial infarction: comparison with 4315 men. Circulation 83: 484-491, 1991.
32. Maynard C., Every N., Martin J., Kudenchuk P., Weaver D.: Association of gender and survival in patients with acute myocardial infarction. Arch. Intern. Med. 157: 1379-1384, 1997.
33. Maynard C., Beshansky J.R., Griffith J.L., Selker H.P.: The influence of gender on the use of cardiac procedures in patients presenting to the emergency department: a prospective multi-center study. Circulation 94 (Suppl. 9): II93-II98, 1996.
34. Kannel W.B., Abbott R.D.: Incidence and prognosis of un-recognised myocardial infarction: an update on the Framingham Study. N. Engl. J. Med. 311: 1144-1147, 1984.
35. Case R.B., Moss A.J., Case N., McDermott M., Eberly S.: Living alone after myocardial infarction: impact on prognosis. JAMA 267: 515-519, 1992.
36. Williams R.B., Barefoot J.C., Califf R.M., Haney T.L., Saunders W.B., Pryor D.B., Hlatky M.A., Siegel I.C., Mark D.B.: Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267: 520-524, 1992.
37. Frasure-Smith N., Lesperance F., Talajic M.: Depression following myocardial infarction: impact on 6-month survival. JAMA 270: 1819-1825, 1993.
38. Barakat K., Wilkinson P., Deaner A., Fluck D., Ranjadayalan K., Timmis A.: How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 353: 955-959, 1999.
39. Vaccarino V., Horvitz R., Meehan T., Petrillo M., Radford M., Krumholz H.: Sex differences in mortality after myocardial infarction. Arch. Intern. Med. 158: 2054-2062, 1998.
40. Vaccarino V., Krumholz H.M., Mendes de Leon C.F., Holford T.R., Seeman T.E., Horwitz R.I., Berkman L.F.: Sex differences in survival after myocardial infarction in older adults: a community-based approach. J. Am. Geriatr. Soc. 44: 1174-1182, 1996.
41. Demirovich J., Blackburn H., McGovern P.G., Luepker R., Sprafka J.M., Gilbertson D.: Sex differences in early mortality after acute myocardial infarction (The Minnesota Heart Survey). Am. J. Cardiol. 75: 1096-1101, 1995.
42. He J., Klag M.J., Whelton P.K., Zhoa Y., Weng X.: Short- and long-term prognosis after acute myocardial infarction in Chinese men and women. Am. J. Epidemiol. 139: 693-703, 1994.
43. Tunstall-Pedoe H., Morrison C., Woodward M., Fitzpatrick B., Watt G.: Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment and 28-day case fatality of 3,991 events in men and 1,551 events in women. Circulation 93: 1981-1992, 1996.
44. Smith W.M.: Epidemiology of congestive heart failure. Am. J. Cardiol. 55: 3A-8A, 1985.
45. Yusuf S., Thom T., Abbot. R.D.: Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 13 (Suppl. 5): 174-179, 1989.
46. Croft J.B., Giles W.H., Pollard R.A., Casper M.L. Anda R.F., Livengood J.R.: National trends in the initial hospitalisation for heart failure. J. Am. Geriatr. Soc. 45: 270-275, 1997.
47. Gillum R.F.: Heart failure in the United States, 1970-1985. Am. Heart J. 113: 1043-1045, 1987.
48. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B.: The natural history of congestive heart failure: the Framingham Study. N. Engl. J. Med. 285: 1441-1446, 1971.
49. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., Levy D.: Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 88: 107-115, 1993.
50. Eriksson H., Svardsudd K., Larsson B., Ohlson L.O., Tibblin G., Welin L., Wilhelmsen L.: Risk factors for health failure in the general population: the study of men born in 1913. Eur. Heart J. 10: 647-656, 1989.
51. Remes J., Reunanen A., Aromaa A., Pyorala K.: Incidence of heart failure in eastern Finland: a population based surveillance study. Eur. Heart J. 13: 588-593, 1992.
52. Parameshwar J., Shackell M.M., Richardson A., Poole-Wilson P.A., Sutton G.C.: Prevalence of heart failure in three general practices in North West London. Br. J. Gen. Pract. 42: 287-289, 1992.
53. Kannel W.B.: Epidemiological aspects of heart failure. Cardiol. Clin. 7: 1-9, 1989.
54. Bonneux L., Barendregt J.J., Meeter K., Bonsel G.J., van der Maas P.J.: Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am. J. Public Health 84: 20-28, 1994.
55. Senni M., Tribouilloy C., Rodeheffer R., Jacobsen S., Evans J., Bailey K., Redfield M.: Congestive heart failure in the community. Trends in incidence and survival in a 10-year period. Arch. Intern. Med. 159: 29-34, 1999.
56. Vaccarino V., Chen Y.T., Wang Y., Radford M.J., Krumholz H.M.: Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am. Heart J. 138: 835-842, 1999.
57. Gillum R.F., Folsom A.R., Blackburn H.: Decline in coronary heart disease mortality: old questions and new facts. Am. J. Med. 76: 1055-1065, 1984.
58. Braunwald E.: Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337: 1360-1369, 1997.
59. Yamani M., Massie B.M.: Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin. Proc. 68: 1214-1218, 1993.
60. 1995 Heart and Stroke Facts; American Heart Association, Dallas, TX, 1996.
61. Lanska D.J.: Geographic distribution of stroke mortality in the United States: 1939-41 to 1979-81. Neurology 43: 1839-1851, 1993.
62. Sacco R., Benjamin E., Broderick J., Dyken M., Easton J.D., Feinberg W.M., Goldstein L.B., Gorelick P.B., Howard G., Kittner S.J., Manolio T.A., Whisnant J.P., Wolf P.A.: Risk Factors - AHA Conference Proceedings. Stroke 28: 1507-1517, 1997.
63. Brown R.D., Whisnant J.P., Sicks R.D., O'Fallon W.M., Wiebers D.O.: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 27: 373-380, 1996.
64. Wolf P.A., D'Agostino R.B., O'Neal M.A., Sytkowsky P., Kase C.S., Belanger A.J., Kannel W.B.: Secular trends in stroke incidence and mortality: the Framingham Study. Stroke 23: 1551-1555, 1992.
65. McGovern P.G., Shahar E., Sprafka J.M., Pankof J.S.: The role of stroke attack rate and case fatality in the decline of stroke mortality: the Minnesota Heart Survey. Ann. Epidemiol. 3: 483-487, 1993.
66. He J., Klag M.J., Wu Z., Whelton P.K.: Stroke in the People's Republic of China. I: geographic variation in incidence and risk factors. Stroke 26: 2222-2227, 1995.
67. Syme S.L., Marmot M.J., Kagan A., Rhoads G.: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am. J. Epidemiol. 102: 477-480, 1975.
68. Du X., Sourbutts J., Cruickshank K., Summers A., Roberts N., Walton E., Holmes S.: A community based stroke registry in a high risk area for stroke in North West England. J. Epidemiol. Comm. Health 51: 472-478, 1997.
69. Tuomilehto J., Rastenyte D., Sivenius J., Sarti C., Immonen-Raiha P., Kaarsalo E., Kuulasmaa K., Narva E., Salomaa V., Salmi K., Torppa J.: Ten year trends in stroke incidence in the FINMONICA Stroke study. Stroke 27: 825-832, 1996.
70. Thorvaldsen P., Asplund K., Kuulasmaa K., Rajakansas A., Schroll M., for the WHO MONICA Project: Stroke incidence, case fatality and mortality in the WHO MONICA Project. Stroke 26: 361-367, 1995.
71. Asplund K., Bonita R., Kuulasmaa K., Rajakangas A., Feigin V., Schaedlich H., Suzuki K., Thorvaldsen P., Tuomiletho J. for the WHO MONICA Project: Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA stroke study. Stroke 26: 355-360, 1995.
72. Stegmayr B., Asplund K.: Trends in incidence, case fatality rate, and severity of stroke in Northern Sweden, 1985-1991. Stroke 25: 1738-1745, 1994.
73. Marmot M., Poulter N.: Primary prevention of stroke. Lancet 339: 344-347, 1992.
74. Hodgson T.A., Cohen A.J.: Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med. Care 37: 994-1012, 1999.
75. Dodd G.D.: Cancer control and the older persons: an overview. Cancer 68: 2493-2495, 1991.
76. Havlik R., Yancik R., Long S., Ries L., Edwards B.: The National Institute on Aging and the National Cancer Institute SEER Collaborative Study on comorbidity and early diagnosis of cancer in the elderly. Cancer 74: 2101-2106, 1994.
77. Cancer Facts and Figures - 1987 American Cancer Society. New York, 8, 1987.
78. Yancik R., Kessler L., Yates J.: The elderly population. Opportunities for cancer prevention and detection. Cancer 62: 1823-1828, 1988.
79. Ferlay J., Bray F., Sankila R., Parkil M.D.: EUROCAN 1995: Cancer incidence, mortality and prevalence in the European Union. IARC Press, Lyon, 1999.
80. Holmes R., Hearne E.: Cancer stage-to-age relationship: implications for cancer screening in the elderly. J. Am. Geriatr. Soc. 29: 1009-1014, 1981.
81. Goodwin J.S., Samet J.M., Key C.R., Humble C., Kutvirt D., Hunt C.: Stage at diagnosis of cancer varies with the age of the patient. J. Am. Geriatr. Soc. 34: 20-26, 1986.
82. Fentiman I.S., Tirelli E., Monfardini S., Schneider M., Festen J., Cognetti F., Aapro M.S.: Cancer in the elderly: why so badly treated? Lancet 335: 1020-1022, 1990.
83. Samet J., Hunt W.C., Key C.R., Humble C.G., Goodwin J.S.: Choice of cancer therapy varies with age of patient. JAMA 255: 3385-3390, 1986.
84. Yancik R., Ries L.: Cancer in the aged. An epidemiologic perspective on treatment issues. Cancer 68: 2502-2510, 1991.
85. Vercelli M., Quaglia A., Casella C., Parodi S., Capocaccia R., Martinez Garcia C., and the EUROCARE Working Group: Relative survival in elderly cancer patients in Europe. Eur. J. Cancer 34: 2264-2270, 1998.
86. Vercelli M., Quaglia A., Casella C., Mangone L.: The ITACARE Working Group: Cancer patients survival in the elderly in Italy. Tumori 83: 490-496, 1997.
87. Kant A.K., Glover C., Horm J., Schatzkin A., Harris B.T.: Does cancer survival differ for older patients? Cancer 70: 2734-2740, 1992.
88. Kane R.A: Psychosocial issues - psychological and social issues for older people with cancer. Cancer 68: 2514-2518, 1991.
89. Micheli A., Mariotto A., Giorgi Rossi A., Gatta G., Muti P., and the EUROCARE Working Group: The Prognostic role of gender in survival of adult cancer patients. Eur. J. Cancer 34: 2271-2278, 1998.
90. Mor V., Masterson-Allen S., Goldberg R.J., Cummings F.J., Glicksman A.S., Fretwell M.D.: Relationship between age at diagnosis and treatments received by cancer patients. J. Am. Geriatr. Soc. 33: 585-589, 1985.
91. Lichtman S.M.: Physiological aspects of aging. Implication for the treatment of cancer. Drugs Aging 7: 212-225, 1995.
92. Black J.S., Sefeik T., Kapoor W.: Health promotion and disease prevention in the elderly. Arch. Intern. Med 150: 389-393, 1990.
93. Hebert R., Brayne C.: Epidemiology of vascular dementia. Neuroepidemiology 14: 240-257, 1995.
94. Aronson M.K., Ooi W.L., Geva D.L., Masur D., Blau A., Frishman W.: Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch. Intern. Med. 151: 989-992, 1991.
95. Bachman D.L., Wolf P.A., Linn R.T., Knoefel J.E., Cobb J.L., Belanger A.J., White L.R., D'Agostino R.B.: Incidence of dementia and probable Alzheirner's disease in a general population: the Framingham Study. Neurology 43: 515-519, 1993.
96. Bickel H., Cooper B.: Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol. Med. 24: 179-192, 1994.
97. Copeland J.R., Davidson I.A., Dewey M.E., Gilmore C., Larkin B.A., McWilliam C., Saunders P.A., Scott A., Sharma V., Sullivan C.: Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br. J. Psychiatry 161: 230-239, 1992.
98. Gussekloo J., Heeren T.J., Izaks G.J., Ligthart G.J., Rooijmans H.G.: A community-based study of the incidence of dementia in subjects aged 85 years and over. J. Neurol. Neurosurg. Psychiatry 59: 507-510, 1995.
99. Letenneur L., Commenges D., Dartigues J.F., Barberger-Gateau P.: Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int. J. Epidemiol. 23: 1256-1261, 1994.
100. Molsa P.K., Marttila R.J., Rinne U.K.: Epidemiology of dementia in a Finnish population. Acta Neurol. Scand. 65: 541-552, 1982.
101. Paykel E.S., Brayne C., Huppert F.A., Gill C., Barkley C., Gehlhaar E., Beardsall L., Girling D.M., Pollitt P., O'Connor D.: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch. Gen. Psychiatry 51: 325-332, 1994.
102. Rorsman B., Hagnell O., Lanke J.: Prevalence and incidence of senile and multi-infarct dementia in the Lundby Study: a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology 15: 122-129, 1986.
103. Kokmen E., Bear C.M., O'Brien P.C., Offord K.P., Kurkland L.T.: Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 43: 1887-1892, 1993.
104. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K.: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45: 1161-1168, 1995.
105. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott M.D., Amaducci L.A., Brayne C., Copeland J.R.M., Dartigues J.F., Kragh-Sorensen P., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A., and the EURODEM Incidence Research Group and Work Groups: Rates and risk factors for dementia and Alzheimer's disease. Results from the EURODEM pooled analyses. Neurology 52: 78-84, 1999.
106. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B.: Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48: 132-138, 1997.
107. Liub C.K., Lai C.L., Tai C.T., Lin R.T., Yen Y.Y., Howng S.L.: Incidence and subtypes of dementia in southern Taiwan: impact of sociodemographic factors. Neurology 50: 1572-1579, 1998.
108. Ott A., Breteler M.M., van Harskamp F., Stijnen T., Hofman A.: Incidence and risk of dementia. The Rotterdam Study. Am. J. Epidemiol. 147: 574-580, 1998.
109. von Strauss E., Viitanen M., De Ronchi D., Winblad B., Fratiglioni L.: Aging and occurrence of dementia. Arch. Neurol. 56: 587-592, 1999.
110. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R.M., Dartigues J.F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A., and the EURODEM Incidence Research Group and Work Groups: Gender differences in the incidence of AD and vascular dementia. The EURODEM Studies. Neurology 53: 1-6, 1999.
111. Gambassi G., Lapane K.L., Landi F., Sgadari A., Mor V., Bernabei R.: Gender differences in the relation between co-morbidity and mortality of patients with Alzheimer's disease. Neurology 53: 508-516, 1999.
112. Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., Dartigues J.F. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J. Neurol. Neurosurg. Psychiatry 66: 177-183, 1999.
113. Snowdon D.A., Kemper S.J., Mortimer J.A., Greiner L.H., Wekstein D.R., Markesbery W.R.: Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: Findings from the Nun Study. JAMA 275: 528-532, 1996.
114. Stern Y., Gurland B., Tatemichi T.K., Tang M.X., Wilder D., Mayeux R.: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271: 1004-1010, 1994.
115. Paganini-Hill A., Henderson V.W.: Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140: 256-261, 1994.
116. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E.: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48: 1517-1521, 1997.
117. Gao S., Hendrie H.C., Hall K.S., Hui S.: The relationships between age, sex and the incidence of dementia and Alzheimer's disease: a meta-analysis. Arch. Gen. Psychiatry 55: 809-815, 1998.
118. Jorm A.F., Jolley D.: The incidence of dementia: a meta-analysis. Neurology 51: 728-733, 1998.
119. Ott A., Slooter A.J.C., Hofman A., van Harskamp F., Witteman J.C.M., Van Broeckhoven C., van Duijn C.M., Breteler M.M.B.: Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351: 1840-1843, 1998.
120. Wang H.X., Fratiglioni L., Frisoni G.V., Viitanen M., Winblad B.: Smoking and the occurrence of Alzheimer's disease: Cross-sectional and longitudinal data in a population-based study. Am. J. Epidemiol. 149: 640-644, 1999.
121. Breitner J.C.S., Wyse B.W., Anthony J.C., Welsh-Bohmer K.A., Steffons D.C., Norton M.C., Tschanz ST., Plassman B.L., Meyer M.R., Skoog I., Khachaturian A.: APOE-∈ 4 count predicts age when prevalence of AD increases then declines. The Cache County Study. Neurology 53: 321-331, 1999.
122. Yamada M., Sasaki H., Mimori Y., Kasagi F., Sudoh S., Ikeda J., Hosoda Y., Nakamura S., Kodama K.: Prevalence and risks of dementia in the Japanese population: RERF's adult health study Hiroshima subject. Radiation Effects Research Foundation. J. Am. Geriatr. Soc. 47: 189-195, 1999.
123. Hamm T.E., Kaplan J.R., Clarkson T.B., Bullock B.C.: Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis 48: 221, 1983.
124. Thom T.J., Epstein F.H., Feldman J.J., Leaverton P.E.: Trends in total mortality and mortality from heart disease in 26 countries from 1950 to 1978. Int. J. Epidemiol. 14: 510, 1985.